Entero Quinol is a direct amoebicidal and antibacterial agent which chemically and pharmacologically closely resembles diiodohydroxyquinoline.
Entero Quinol is effective in the treatment of acute and chronic amoebic dysentery, colitis.
Hypersensitivity to the drug or iodine, hepatic damage or pre-existing optic neuropathy.
Optic neuritis, optic atrophy and peripheral neuropathy are reported to occur with high dosage for prolonged period. Other side effects that may occur, though rarely, include irritation, transient abdominal discomfort, etc.
Rash may appear during therapy with Entero Quinol when the drug should be discontinued. Safe use during pregnancy and lactation has not been established.
Adults :2 tablets thrice daily after meals for 10 days or as directed by the physician.
To be repeated after an interval of 8 days.
Children :Proportionate to the adults.
Strips of 20 tablets.
On April 27, 1936, East India Pharmaceutical Works Limited, one of the oldest pharmaceutical companies in India, was born. It started with the extraordinary vision of an extraordinary man, Late Ashoke Kumar Sen. Few years later, another visionary and also an extraordinary man, Late Hirendranath Dutt Gupta joined Late Ashoke Kumar Sen and led the company towards its present heights.
The object was simple - to develop, through private entrepreneurship, an organization to synthesize modern drugs from basic chemicals and cater to the needs of the millions.
Depending solely on national resources and talents - East India Pharmaceutical Works Limited ( EIPWL ) now has emerged as a large pharmaceutical company with three manufacturing units, workforce of 1500 employees and an annual turnover of around Rs.800 million.With forward looking ideas, R&D orientation, quality consciousness and a strong financial fundamental, East India Pharmaceutical Works Limited is determined to open up new horizons.
East India Pharmaceutical Works Limited
6,Nandalal Bose Sarani
Kolkata - 700071 West Bengal, India